BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Ischemia, Prostate, Anticancer prodrugs, Doxorubicin, rs2300478, PPARA, Coagulation)
Bookmark Forward

QuickView for ERCC6L;jsessionid=F2A9B3A62B4F54EBB1D58612896F9490;jsessionid=1706F53E848DD106B154F31BFACC00BA (gene)


Body Atlas

Most Correlated Tissues

  1. Hematopoietic stem cell of bone marrow
  2. Granulocyte-macrophage progenitor cell of bone marrow
  3. T Lymphocyte (regulatory) of peripheral blood
  4. Basophil of peripheral blood
  5. Endometrium
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Anal penetration by penis
  2. Microbial culture finding
  3. Severe acute respiratory syndrome
  4. Viral disease
  5. Viral infections of the central nervous system
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Cholesterol, HDL
  2. Anti-Retroviral Agents
  3. Antigens, Polyomavirus Transforming
  4. salubrinal
  5. PTC-209
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. OTUD1
  2. TOP2B
  3. XIAP
  4. ANGPT2
  5. PCLAF
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. RAD52 and ERCC6L/PICH have a compensatory relationship for genome stability in mitosis.
  2. ERCC6L facilitates the progression of laryngeal squamous cell carcinoma by the binding of FOXM1 and …
  3. PICH Activates Cyclin A1 Transcription to Drive S-Phase Progression and Chemoresistance in Gastric C…
  4. ERCC6L facilitates the onset of mammary neoplasia and promotes the high malignance of breast cancer …
  5. FIRRM/C1orf112 is synthetic lethal with PICH and mediates RAD51 dynamics.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for ERCC6L;jsessionid=F2A9B3A62B4F54EBB1D58612896F9490;jsessionid=1706F53E848DD106B154F31BFACC00BA
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.